



Interictal dysphoric disorder: a frequent 
psychiatric comorbidity among patients 
with epilepsy who were followed in  
two tertiary centers
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ABSTRACT
Psychiatric disorders are frequent among patients with epilepsy. Data in the literature have shown a heterogeneous clinical presentation of 
psychiatric disorders in patients with epilepsy. Interictal dysphoric disorder could be a specific psychiatric comorbidity associated with epi-
lepsy, primarily in patients treated in tertiary centers. Objective: The present study aimed to determine the prevalence of interictal dysphoric 
disorder among patients with epilepsy who were followed in two tertiary epilepsy services in Brazil. Method: Sixty-five patients with epilepsy 
completed the Portuguese version of the Interictal Dysphoric Disorder Inventory. Results: Thirty-three (50.7%) patients fulfilled the diagnos-
tic criteria for interictal dysphoric disorder, although all participants answered positively to having at least one key symptom. Conclusion: The 
high rate of patients with epilepsy who fulfilled the diagnosis of interictal dysphoric disorder confirms an association between epilepsy and 
psychiatric disorders. However, there is clearly a need to improve diagnostic tools to allow better differentiation between interictal dysphoric 
disorder and other psychiatric disorders. 
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RESUMO
Transtornos psiquiátricos são frequentes entre pacientes com epilepsia. Estudos evidenciam apresentações clínicas heterogêneas neste gru-
po. O transtorno disfórico interictal pode um transtorno específico destes pacientes, particularmente naqueles acompanhados em centros 
terciários. Objetivo: Determinar a prevalência de transtorno disfórico interictal entre pacientes com epilepsia atendidos em dois serviços ter-
ciários de epilepsia do Brasil. Método: Sessenta e cinco pacientes foram convidados a responder a versão brasileira do Interictal Dysphoric 
Disorder Inventory adaptado e validado para o Português. Resultados: Trinta e três pacientes (50,7%) preencheram critérios para transtorno 
disfórico interictal, embora todos os entrevistados tenham afirmado que são acometidos por ao menos um dos sintomas-chave. Conclusão: 
A alta prevalência de transtorno disfórico interictal em pacientes com epilepsia pode ser um indício da associação entre epilepsia e transtor-
nos psiquiátricos. No entanto, é necessário melhorar a acurácia dos instrumentos de diagnóstico para poder diferenciar casos de transtorno 
disfórico interictal de outros transtornos psiquiátricos.
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INTRODUCTION
Epilepsy is one of the most prevalent neurological con-
ditions and is the most common chronic neurologic dis-
order in the general population. Studies in the literature 
indicate that up to 50% of patients with epilepsy (PWE) 
have psychiatric disorders (PDs) such as mood, anxiety and 
psychotic disorders1. The appearance of a PD is probably 
the result of multiple clinical features (e.g., age of onset, 
type and frequen cy of seizures, localization of epileptogenic 
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zone, antiepileptic drugs) and psychosocial features (e.g., 
stigma, familial support)1-3. 
Psychiatric disorders are not properly recognized and 
treated among PWE, despite their high prevalence1. This 
could result from two issues. First, the clinical presenta-
tion of PDs in PWE may be phenomenologically heteroge-
neous, suggesting that PDs in epilepsy would be clinically 
distinct and configure a spectrum in which PD cases com-
parable to PDs in patients without epilepsy (who fulfill cur-
rent diagnosis criteria) coexist with subtle PD cases that are 
not classified according to the criteria of the Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV) 
and the International Classification of Diseases–10th Revision 
(ICD-10)2,4. Second, the reluctance to treat these comor-
bidities may result from traditional beliefs that some symp-
toms are attributable to antiepileptic medication and that 
psychiatric drugs should be restricted in patients with 
epilepsy because the drugs supposedly lower the seizure 
threshold. Efforts are being made to reverse this situation5. 
The International League Against Epilepsy (ILAE) commis-
sion on the psychobiology of epilepsy has evolved through 
this process and developed an expert consensus that was di-
rected to provide a more comprehensive and acceptable sys-
tem of classification for PD in epilepsy6.
Interictal dysphoric disorder (IDD) was first described by 
Kraepelin7 in 1923. He observed a clinical state in PWE that 
he called “verstimmungszustand” (i.e., “depressive state”), 
which comprised intermittent manifestations of psychiatric 
symptoms that appeared and disappeared faster than in bi-
polar disorder. In 1984, Himmelhoch8 described a “dysthymic 
interictal subictal state” in patients with a moderate chronic 
state of depression during seizure-free periods. In descri bing 
the same manifestation, Blumer9 preferred the term “dys-
phoric” because this term would be the best translation of 
Kraepelin’s initial idea, especially concerning the frequency 
and periodicity of the mood swings, irritability, and aggres-
sive outbursts. 
More recently, Mula et al.10 have developed and opera-
tionalized the concept of an IDD diagnosis by forming the 
Interictal Dysphoric Disorder Inventory (IDDI), which is a 
38-item, self-report questionnaire specifically developed to 
diagnose IDD and to evaluate eight IDD core symptoms in 
terms of symptom presence, symptom frequency, symptom 
severity, and global impairment9-11. The IDDI was constructed 
based on the main core symptoms of IDD, characterized by 
eight key symptoms divided into three categories: (1) labile 
depressive symptoms (e.g., depressed mood, anergia, pain, in-
somnia), (2) labile affective symptoms (e.g., panic symptoms 
and anxiety), and (3) “specific symptoms” (e.g., paroxystic ir-
ritability and instable euphoric moods). The Brazilian version 
of the IDDI (available in the medical literature since 2011) has 
also allowed a more specific approach to diagnosing IDD in 
the Brazilian population12.
Because there is a scarcity of studies measuring the preva-
lence and the frequency of core symptoms of IDD among PWE, 
the present study aimed to determine-through using the IDDI-
the prevalence of IDD and to characterize its symptoms in pa-
tients treated at two tertiary Brazilian epilepsy services. 
METhOD 
From October 2011 to October 2012, all patients were 
 followed up at the outpatient clinic of the Epilepsy Section of 
the Universidade Federal de São Paulo (São Paulo, Brazil) and 
Universidade Federal de Pernambuco, Recife (Pernambuco, 
Brazil). The inclusion criteria were: 
1. A diagnosis of epilepsy, based on the ILAE criteria; 
2. Age over 18 years; 
3. A lack of gross cognitive deficits and a reading ability 
sufficient to manage the questionnaire; 
4. An absence of severe medical diseases; 
5. Patient willingness to provide written, informed con-
sent to undergo the experimental procedures.
After providing informed consent, the patients completed 
a questionnaire eliciting clinical and sociodemographic 
 information such as gender, age, schooling, duration of epi-
lepsy, type and frequency of seizures, and drug treatment. 
After filling out this initial questionnaire, the patients were 
assessed through the Portuguese version of the IDDI. As re-
commended by Mula et al.10, patients were considered to 
have IDD if they had at least three core symptoms that were 
mode rate or severe and caused moderate or severe distress 
for an period of 12 months.
RESULTS
Sixty-five (63.1%) patients (41 females) with mean age 
of 35.2±10.2 years were included in the study. All patients 
 responded positively to at least one IDD symptom (Figure 1) 
and 33 (50.7%) patients, 22 (66.7%) of whom were females, 
fulfilled the diagnostic criteria for IDD. The IDD symptoms 
are reported for more than 80% of patients, except insomnia, 
euphoric moods and panic symptoms, with their occurrence 
had a similar distribution in both groups (Figure 2).
DISCUSSION
The present study was aimed at determining the preva-
lence of IDD and describing its core symptoms in patients 
treated at two tertiary Brazilian epilepsy services. To our 
knowledge, this is the first study to use the Brazilian version 
of IDDI to recognize this possibly very frequent and under-
diagnosed psychiatric comorbidity among PWE.
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medical literature. Himmelhoch8 described a 10% prevalence 
of patients presenting with “dysthymic symptoms”, whereas 
Mula11 found that 21.8% of patients fulfilled the criteria for 
IDD. Two reasons that may have contributed to the higher 
IDD prevalence in the present study are the small number of 
participants and the presence of other common PDs, such as 
mood and anxiety disorders. Because the IDDI cannot accu-
rately differentiate IDD symptoms from the symptomatology 
of other PDs, the concomitant application of other diagnostic 
psychiatric instruments has been recommended10-12.
In the present study, the key symptoms of IDD were highly 
prevalent. More than 80% of all patients reported labile de-
pressive and affective symptoms, but specific symptoms such 
as euphoric mood were observed in only 60%, which has been 
observed in other studies10,11. 
The preponderance of depressive and irritability symp-
toms could be explained, at least partially, by the concept 
of forced normalization. According to this idea, psychia-
tric symptoms in PWE could be the consequence of a phy -
siologic or drug-related exacerbation of inhibitory brain ac-
tivity against the appearance of an exacerbated excitatory 
epileptic activity9,13. Blummer et al.9 have suggested that an-
tidepressant drugs are highly effective at lower doses against 
all IDD symptoms because the drugs antagonize excessive 
cerebral inhibition. In the same manner, if psychotic symp-
toms were present, the treatment would be enhanced through 
the use of antipsychotic medication. However, more studies 
are necessary to clarify these clinical aspects and to test a 
phar macological treatment for IDD and its pathophysiologi-
cal underpinnings. 
In accordance with the medical literature, the present 
study disclosed a high prevalence of IDD among PWE who 
were followed in two tertiary epilepsy centers. These results 
highlight the necessity of improving diagnostic tools such as 
the Brazilian version of the IDDI to allow better evaluation of 
IDD and its differentiation from other PDs in PWE. However, 
the expressive IDD symptoms that result in moderate to severe 
distress and in moderate to severe severity in PWE demons-
trate a real need for improvements in diagnosis and care. 
This study disclosed that IDD was present in 50.7% of 
 patients, which was similar to the prevalence observed in 
the study that produced the translation and transcultural 
 adaptation of the Brazilian version of the IDDI12. These values 
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IDD: interictal dystrophic disorder.
Figure 2. Interictal dysphoric disorder symptom frequency 
with moderate or severe distress and severity. 
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